CID 644241

Nilotinib

Structural Information

Molecular Formula
C28H22F3N7O
SMILES
CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
InChI
InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37)
InChIKey
HHZIURLSWUIHRB-UHFFFAOYSA-N
Compound name
4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide
Related CIDs

2D Structure

compound 2d structure
8
Annotation Hits

1952
References

57544
Patents

529.1838 Da
Monoisotopic Mass

4.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 530.19108 226.5
[M+Na]+ 552.17302 234.2
[M-H]- 528.17652 233.1
[M+NH4]+ 547.21762 225.6
[M+K]+ 568.14696 223.8
[M+H-H2O]+ 512.18106 209.4
[M+HCOO]- 574.18200 239.7
[M+CH3COO]- 588.19765 231.5
[M+Na-2H]- 550.15847 227.1
[M]+ 529.18325 223.3
[M]- 529.18435 223.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe